Latest News and Press Releases
Want to stay updated on the latest news?
-
Oxford Healthspan announces that its longevity supplement Primeadine® GF has been named a 2026 NEXTY Awards Finalist.
-
PAI-1 Inhibitor (MDI-2517) demonstrates good safety and tolerability profile, with Phase 2 proof-of-concept trial planned for 2026 in patients with metabolic and fibrotic diseaseCarmel Nanthakumar,...
-
A Media Snippet accompanying this announcement is available by clicking on this link. ATLANTA, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Countdown For A Cure (CFAC) hosted its third annual Evening of...
-
New York, N.Y., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Human Continuum Inc. (“HC” or “the Company”), a developer of platelet-derived and plant-based exosome therapeutics and diagnostics, today announced...
-
Nucleus Preview is a new preconception test for couples that combines rare and chronic disease screening with trait modeling for the first time ever.
-
Serotonin Anti-Aging Centers Awards Five-Location Development Agreement for Dallas and Collin County
Serotonin Anti-Aging Centers signs five-location Dallas development deal, expanding physician-led longevity and wellness across North Texas.
-
Jennings-Brown will drive AI and technology strategy and lead the development of capabilities enabling discovery of therapeutics targeting fundamental aging mechanisms Offices in Abu Dhabi's premier...
-
Serotonin Centers opens its first Illinois location at Block 59 in Naperville, bringing physician-led longevity and aesthetic care to Chicagoland.
-
The Precision Health and Longevity Summit hosted by DIL Walk Foundation recognizes that aging is not a regional issue, but a global demographic shift.
-
ORLANDO, Fla., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Wesley Pharmaceuticals, a state-of-the-art 503B outsourcing facility, and sister brand of the nation’s leading 503A and 503B compounding pharmacy,...